Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
Abercrombie & Fitch
downgraded at Brean from Hold to Sell. Valuation call, based on a $36 price target.
initiated at Credit Suisse with an Outperform rating and $25 price target.
The DirecTV Group
initiated at Credit Suisse with a Neutral rating and $33 price target.
downgraded at Susquehanna to Neutral. $19 price target. Company lacks near-term catalysts.
downgraded at Goldman from Buy to Neutral. $53 price target. Offshore wind project could produce further losses.
cut from Top Picks Live at Citigroup list. Company lowered its guidance. New $13.50 price target.
downgraded at Soleil to Hold. $11.50 price target. Estimates also cut, to reflect the company's new guidance.
downgraded at Wells Fargo from Outperform to Market Perform. Stock is already up a quick 55% from its IPO.
downgraded at FBR from Outperform to Market Perform. Valuation call, based on a $30 price target.
Time Warner Cable
upgraded at Credit Suisse to Outperform from Neutral. Strong fundamentals given economic headwinds. Expect a buyback program to be announced soon. Price target raised to $70 from $59.
estimates upped at UBS through 2011. Company boosted guidance, though bookings are down. Buy rating and $100 price target.
downgraded at William Blair from Outperform to Market Perform. Virtualization market has become more penetrated.
STOCK COMMENTS / EPS CHANGES
estimates, target boosted at Citigroup. Shares of AAPL now seen reaching $390. Estimates also upped, given higher iPhone sales. Buy rating.
estimates, target upped at Morgan Stanley. AAPL estimates were boosted through 2012. Company is seeing better sales across the boar. Overweight rating and new $375 price target.
estimates, target increased at Jefferies. AGN estimates were raised through 2011, Jefferies said. Botox migraine approval could be a $250 million opportunity. Hold rating.
target lowered at UBS. Shares of APOL now seen reaching $40. 2011 will be a transition year for the company. Neutral rating.
estimates increased at UBS through 2011. Promus Element should drive margin expansion. Buy rating and $6.85 price target.
price target increased at Credit Suisse to $37 from $34 due to faster growth. Maintain Outperform rating.
target boosted at Goldman to $300. New interest rate swap clearing platform should help drive growth. Neutral rating.
estimates, target raised at Morgan Stanley. Shares of CNK now seen reaching $17. Estimates also increased, given stronger international results. Underweight rating.
estimates increased at Morgan Stanley through 2012. Company is releasing reserves and doesn't face major capital concerns. Equal-weight rating and $46 price target.
( CPO) numbers raised at Citigroup. Shares of CPO now seen reaching $44. Estimates also increased, because of rising corn prices. Hold rating.
target boosted at Morgan Stanley to $49. Company will likely lower its share count and looks attractive on expected 2011 earnings. Overweight rating.
estimates, target increased at ThinkEquity. FTNT estimates were raised through 2011. Checks suggest that the company is gaining market share. Buy rating and new $30 price target.
estimates, target increased at Citigroup. HAL estimates were raised through 2011. Expect international pricing to rise and dry gas plays should pay off. Buy rating and new $47 price target.
target raised at FBR to $40. Company is looking to grow its market share through pricing, despite rising industry capacity. Market Perform rating.
estimates, target boosted at Goldman. Shares of HAS now seen reaching $62. Estimates also upped, to reflect higher sales and the weaker dollar. Buy rating.
target, estimates boosted at Barclays. IMB price target raised to $153 from $145. Strong 3Q10 results highlight the bookings trend again. 2010 and 2011 EPS estimates increased to $11.42 and $12.68, respectively. Maintain Equal Weight rating.
estimates, target upped at Citigroup. IBM estimates were boosted through 2011. Company continues to see strong hardware demand. Buy rating and new $160 price target.
estimates lowered at Morgan Stanley through 2012. Software and services demand remains choppy. Equal-weight rating.
target boosted at UBS. Shares of NTAP now seen reaching $58. Company has a competitive advantage and should be able to sustain above-average operating margins.
estimates, target raised at Morgan Stanley. Shares of PCG now seen reaching $49. Estimates also increased, following the company's latest rate case settlement. Equal-weight rating.
estimates reduced at Citigroup through 2011. Company likely offering higher subsidies to attract 4G customers. Buy rating and $6 price target.
estimates, target boosted at Citigroup. Shares of STJ now seen reaching $37. Estimates also upped, as the company is gaining market share and should benefit from a weaker dollar. Sell rating.
price target raised at Barclays to $84, up from $82. Industrial recovery will provide further earnings upside. 2011 EPS estimate lifted to $4.20. Maintain Overweight rating.
price target raised at Credit Suisse to $55 from $50. Growth and margin uplift peaking. Maintain Underperform rating.
numbers upped at Citigroup. ZION estimates were boosted through 2011. Credit metrics continue to improve. Hold rating and new $23 price target.
This article was written by a staff member of TheStreet.